Dr. Ernest J Hook, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1580 Creekside Dr, Suite 110, Folsom, CA 95630 Phone: 916-984-7912 Fax: 916-984-7910 |
John M. Dawson, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1730 Prairie City Rd, Suite 120, Folsom, CA 95630 Phone: 916-351-4800 Fax: 916-351-4899 |
Robert Wayne Larsen, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1600 Creekside Dr, Ste 3100, Folsom, CA 95630 Phone: 916-983-8555 Fax: 916-983-8568 |
Bay Area Foot Care, Inc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1580 Creekside Dr Ste 110, Folsom, CA 95630 Phone: 916-984-7912 Fax: 916-961-0540 |
Ernest J. Hook Dpm Inc. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1580 Creekside Dr. #110, Folsom, CA 95630 Phone: 916-984-7912 Fax: 916-984-7910 |
Bay Area Foot Care, Inc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1580 Creekside Dr Ste 100, Folsom, CA 95630 Phone: 916-961-3434 Fax: 916-961-0540 |
Bay Area Foot Care, Inc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1600 Creekside Dr Ste 3100, Folsom, CA 95630 Phone: 916-983-8555 Fax: 916-435-5231 |
News Archive
A recent study led by MedImpact Healthcare Systems, Inc. investigated a pilot Value-Based Benefit Design program to improve adherence to diabetes medications. The study found that a VBBD program that reduced copayments for diabetes medications by 36 percent reduced the number of non-adherent patients by 30 percent.
"The nation's deep recession is helping to alleviate the decade-long nursing shortage, as workers who had left the field in better times are returning in droves," the Wall Street Journal reports.
The National Cancer Coalition (NCC) is pleased to announce its recent collaboration with Pfizer, Inc to provide hemophilia medicines to underserved patients in the developing world. To date, NCC has received more than 10 million international units of ReFacto® Antihemophilic Factor (Recombinant), a therapy used for the treatment and prevention of bleeding in people with hemophilia A, to assist patients who otherwise would have little opportunity for adequate treatment. The value of this donation is more than $13 million, and it will help many hundreds of hemophilia patients around the world.
UT Southwestern Medical Center is one of a handful of top research institutions evaluating a promising new medication researchers hope can reduce the severity and frequency of asthma attacks in inner-city children, a population known to have a high prevalence of severe asthma.
In this interview, we speak to Dr. Joshua E. Rosen about his latest research into treatment options and what role a surgeon's language plays in people's perception of its risks.
› Verified 5 days ago